Scientists have developed a new tool that may prove to be invaluable for investigating the long-term mutagenic effects of chemotherapy and radiation, therapies that are widely used for the treatment of cancer. The research study, published in the October issue of Cancer Cell, provides evidence that a genetically engineered mouse model faithfully recapitulates treatment-associated cancers that occur in humans and may be useful for investigating the mechanisms involved in the development of therapy-induced cancers and for testing preventive strategies.
Secondary malignant neoplasms (SMNs) are new cancers that patients develop as a result of having received chemotherapy or radiation to treat a different type of cancer that may have occurred years earlier. To make matters worse, many of these secondary cancers are notoriously resistant to treatment. The occurrence of SMNs is a serious concern for doctors and patients, as the use of intensive radiation and chemotherapy has been more successful in curing primary cancers and has dramatically increased survival rates in children and adults. Unfortunately, as a result of treatment success, the incidence of SMNs has also risen. "The lack of relevant animal models of SMNs has impeded efforts to understand how mutagenic cancer therapeutics induce tumors in vivo, and to test preventive strategies," explains study author Dr. Kevin Shannon, a pediatric oncologist at the University of California, San Francisco.
Dr. Shannon and colleagues used a strain of mice developed in the laboratory of Dr. Tyler Jacks that carry a mutation in a tumor suppressor gene called Nf1. They selected this strain based on clinical data suggesting that humans who inherit this mutation are predisposed to SMNs. Nf1 mutant mice that were exposed to radiation, or radiation combined with chemotherapy, developed secondary cancers that are common in humans including leukemia, sarcoma, and breast cancers. "These animals develop a similar spectrum of malignancies as human patients who are treated with radiation and alkylating agents, and provide a tractable system for performing mechanistic studies, for comparing the mutagenic potential of different regimens, and for testing preventive strategies," offers Dr. Shannon. The study authors also suggest that this mouse model may be useful for testing novel therapeutic strategies for tumors that are resistant to conventional cancer therapies.
Resolving the mystery of preeclampsia
21.10.2016 | Universitätsklinikum Magdeburg
New potential cancer treatment using microwaves to target deep tumors
12.10.2016 | University of Texas at Arlington
Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.
"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...
In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.
A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...
By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.
"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...
COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.
In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...
'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.
Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...
14.10.2016 | Event News
14.10.2016 | Event News
12.10.2016 | Event News
21.10.2016 | Health and Medicine
21.10.2016 | Information Technology
21.10.2016 | Materials Sciences